LAEKNA-B (02105) completed the issue of 36 million shares of allocated shares.
Kailai Pharmaceuticals-B (02105) has announced that all conditions for the allotment have been met, and the allotment has been completed on ...
Notice from LAEKNA-B (02105): The conditions for the allotment have all been met, and the allocation was completed on September 17, 2025. According to the terms and conditions of the allotment agreement, 36 million shares have been successfully allocated to no fewer than six underwriters by the exclusive allotment agent at a price of HK$16.30 per share.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
